Beneficial effects of Lactobacillus paracasei subsp. paracasei NTU 101 and its fermented products
Resource
Appl Microbiol Biotechnol,93(3),903-916.
Journal
Applied Microbiology and Biotechnology
Journal Volume
93
Journal Issue
3
Pages
903-916
Date Issued
2012
Author(s)
Abstract
It is well-known that probiotics have a number of beneficial health effects in humans and animals, including the reduction of symptoms in lactose intolerance and enhancement of the bioavailability of nutrients. Probiotics have showed to possess antimutagenic, anticarcinogenic and hypocholesterolemic properties. Further, they were also observed to have antagonistic actions against intestinal and food-borne pathogens, to decrease the prevalence of allergies in susceptible individuals and to have immunomodulatory effects. Typically, the bacteria colonise the intestinal tract first and then reinforce the host defence systems by inducing a generalised mucosal immune response, balanced T-helper cell response, self-limited inflammatory response and secretion of polymeric IgA. Scientific reports showed that the Taiwan native lactic acid bacterium from newborn infant faeces identified as Lactobacillus paracasei subsp. paracasei NTU 101 and its fermented products proved to be effective for the management of blood cholesterol and pressure, prevention of gastric mucosal lesion development, immunomodulation and alleviation of allergies, anti-osteoporosis and inhibition the fat tissue accumulation. This review article describes that the beneficial effects of this Lactobacillus strains and derivative products may be suitable for human and animals. ? 2011 Springer-Verlag.
Subjects
Gastric mucosal lesion; Hyperlipidemia; Hypertension; Lactobacillus paracasei subsp. paracasei NTU 101; Obesity; Osteoporosis
SDGs
Other Subjects
Gastric mucosal lesion; Hyperlipidemia; Hypertension; Lactobacillus paracasei subsp. paracasei NTU 101; Obesity; Osteoporosis; Allergies; Bacilli; Biochemistry; Cholesterol; Lactic acid; Sugars; Tissue; Animals; immunoglobulin A; polymer; probiotic agent; bacterium; bioavailability; biotechnology; blood; bone; digestive system; disease prevalence; disease treatment; fermentation; health impact; hypertension; immune response; lesion; mucus; native species; obesity; probiotics; secretion; subspecies; symptom; adipose tissue; allergy; animal experiment; animal tissue; antihypertensive activity; atopy; bacterial strain; cholesterol blood level; controlled study; diet supplementation; feces analysis; fermented product; helper cell; host resistance; hypocholesterolemia; immune response; immunomodulation; infancy; inflammation; intestine; intestine flora; lactic acid bacterium; Lactobacillus paracasei; lipid storage; newborn period; nonhuman; rat; review; soybean milk; stomach mucosa injury; Taiwan; Animals; Cricetinae; Female; Fermentation; Gastrointestinal Diseases; Humans; Hypercholesterolemia; Immunity, Mucosal; Infant, Newborn; Lactobacillus; Mice; Mice, Inbred C57BL; Obesity; Osteoporosis; Probiotics; Rats; Taiwan; Animalia; Bacteria (microorganisms); Lactobacillus; Lactobacillus paracasei subsp. paracasei
Type
journal article